Proteasome inhibitor immunotherapy for the epithelial to mesenchymal transition: assessing the A549 lung cancer cell microenvironment and the role of M1, M2a and M2c ‘hydrocortisone-polarised’ macrophages
Selin Engür, Miriş Dikmen
Topics & Concepts
A549 cellCancer researchEpithelial–mesenchymal transitionVimentinLung cancerTumor microenvironmentProteasome inhibitorCancer cellCancerMetastasisChemistryImmunotherapyApoptosisImmunologyMedicinePathologyInternal medicineImmunohistochemistryBiochemistryImmune cells in cancerEpigenetics and DNA MethylationCancer Immunotherapy and Biomarkers